NAUT ▲ +1.1% - Nautilus Biotechnology, Inc. $NAUT - Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms Nautilus Biotechnology shares rose 1.1% following publication of research in Nature Methods describing the company's ability to quantify tau proteoforms—different forms of the tau protein implicated in neurodegeneration—using its proteomics platform. The peer-reviewed validation of the company's technology's capability to generate novel biological insights may have bolstered investor confidence in the commercial potential of its functional proteomics approach. 04-SEP-2026 08:01 AM ET